Anti-IL-8 monoclonal antibodies for treatment of inflammatory disorders
US5702946A · kind A · utility
39Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 1995 |
| Grant date | Dec 30, 1997 |
| Priority date | — |
| Expiry date | Mar 1, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-IL-8 monoclonal antibodies are described for use in diagnostic applications and in the treatment of inflammatory disorders such as inflammatory bowel disease and bacteria pneumonias.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.